Frank has been publishing on data monitoring issues for more than 25 years and, for more than 15 years, was responsible for overseeing the creation of hundreds of data monitoring committees in his time at GlaxoSmithKline.  In addition, as head of the safety department, he was the point person for all communications with these committees.  Now as a member of academia, he serves on several independent data monitoring committees and is helping to develop a training program for data monitoring committees and training of new committee members as a member of Duke Clinical Research Institute.    Frank can help organize and serve on an independent data monitoring committee for an individual clinical trial or a series of trials within a research program.